Cargando…
Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery
Background and Objectives: Transaxillary access is one of the latest innovations for minimally invasive aortic valve replacement (MICS-AVR). This study compares clinical performance in a large transaxillary MICS-AVR group to a propensity-matched sternotomy control group. Materials and Methods: This...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860976/ https://www.ncbi.nlm.nih.gov/pubmed/36676784 http://dx.doi.org/10.3390/medicina59010160 |
_version_ | 1784874725821906944 |
---|---|
author | Wilbring, Manuel Alexiou, Konstantin Schmidt, Torsten Petrov, Asen Taghizadeh-Waghefi, Ali Charitos, Efstratios Matschke, Klaus Arzt, Sebastian Kappert, Utz |
author_facet | Wilbring, Manuel Alexiou, Konstantin Schmidt, Torsten Petrov, Asen Taghizadeh-Waghefi, Ali Charitos, Efstratios Matschke, Klaus Arzt, Sebastian Kappert, Utz |
author_sort | Wilbring, Manuel |
collection | PubMed |
description | Background and Objectives: Transaxillary access is one of the latest innovations for minimally invasive aortic valve replacement (MICS-AVR). This study compares clinical performance in a large transaxillary MICS-AVR group to a propensity-matched sternotomy control group. Materials and Methods: This study enrolled 908 patients undergoing isolated AVR with a mean age of 69.4 ± 18.0 years, logistic EuroSCORE of 4.0 ± 3.9%, and body mass index (BMI) of 27.3 ± 6.1 kg/m(2). The treatment group comprised 454 consecutive transaxillary MICS-AVR patients. The control group was 1:1 propensity-matched out of 3115 consecutive sternotomy aortic valve surgeries. Endocarditis, redo, and combined procedures were excluded. The multivariate matching model included age, left ventricular ejection fraction, logistic EuroSCORE, pulmonary hypertension, coronary artery disease, chronic lung disease, and BMI. Results: Propensity-matching was successful with subsequent comparable clinical baselines in both groups. MICS-AVR had longer skin-to-skin time (120.0 ± 31.5 min vs. 114.2 ± 28.7 min; p < 0.001) and more frequent bleeding requiring chest reopening (5.0% vs. 2.4%; p < 0.010), but significantly less packed red blood cell transfusions (0.57 ± 1.6 vs. 0.82 ± 1.6; p = 0.040). In addition, MICS-AVR patients had fewer access site wound abnormalities (1.5% vs. 3.7%; p = 0.038), shorter intensive care unit stays (p < 0.001), shorter ventilation times (p < 0.001), and shorter hospital stays (7.0 ± 5.1 days vs. 11.1 ± 6.5; p < 0.001). No significant differences were observed in stroke > Rankin 2 (0.9% vs. 1.1%; p = 0.791), renal replacement therapy (1.5% vs. 2.4%; p = 0.4762), and hospital mortality (0.9% vs. 1.5%; p = 0.546). Conclusions: Transaxillary MICS-AVR is at least as safe as AVR by sternotomy and can be performed in the same time frame. Its advantages are fewer transfusions and quicker postoperative recovery with a significantly shorter hospital stay. The cosmetic result and unrestricted physical abilities due to the untouched sternum and ribs are unique advantages of transaxillary access. |
format | Online Article Text |
id | pubmed-9860976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98609762023-01-22 Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery Wilbring, Manuel Alexiou, Konstantin Schmidt, Torsten Petrov, Asen Taghizadeh-Waghefi, Ali Charitos, Efstratios Matschke, Klaus Arzt, Sebastian Kappert, Utz Medicina (Kaunas) Article Background and Objectives: Transaxillary access is one of the latest innovations for minimally invasive aortic valve replacement (MICS-AVR). This study compares clinical performance in a large transaxillary MICS-AVR group to a propensity-matched sternotomy control group. Materials and Methods: This study enrolled 908 patients undergoing isolated AVR with a mean age of 69.4 ± 18.0 years, logistic EuroSCORE of 4.0 ± 3.9%, and body mass index (BMI) of 27.3 ± 6.1 kg/m(2). The treatment group comprised 454 consecutive transaxillary MICS-AVR patients. The control group was 1:1 propensity-matched out of 3115 consecutive sternotomy aortic valve surgeries. Endocarditis, redo, and combined procedures were excluded. The multivariate matching model included age, left ventricular ejection fraction, logistic EuroSCORE, pulmonary hypertension, coronary artery disease, chronic lung disease, and BMI. Results: Propensity-matching was successful with subsequent comparable clinical baselines in both groups. MICS-AVR had longer skin-to-skin time (120.0 ± 31.5 min vs. 114.2 ± 28.7 min; p < 0.001) and more frequent bleeding requiring chest reopening (5.0% vs. 2.4%; p < 0.010), but significantly less packed red blood cell transfusions (0.57 ± 1.6 vs. 0.82 ± 1.6; p = 0.040). In addition, MICS-AVR patients had fewer access site wound abnormalities (1.5% vs. 3.7%; p = 0.038), shorter intensive care unit stays (p < 0.001), shorter ventilation times (p < 0.001), and shorter hospital stays (7.0 ± 5.1 days vs. 11.1 ± 6.5; p < 0.001). No significant differences were observed in stroke > Rankin 2 (0.9% vs. 1.1%; p = 0.791), renal replacement therapy (1.5% vs. 2.4%; p = 0.4762), and hospital mortality (0.9% vs. 1.5%; p = 0.546). Conclusions: Transaxillary MICS-AVR is at least as safe as AVR by sternotomy and can be performed in the same time frame. Its advantages are fewer transfusions and quicker postoperative recovery with a significantly shorter hospital stay. The cosmetic result and unrestricted physical abilities due to the untouched sternum and ribs are unique advantages of transaxillary access. MDPI 2023-01-13 /pmc/articles/PMC9860976/ /pubmed/36676784 http://dx.doi.org/10.3390/medicina59010160 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wilbring, Manuel Alexiou, Konstantin Schmidt, Torsten Petrov, Asen Taghizadeh-Waghefi, Ali Charitos, Efstratios Matschke, Klaus Arzt, Sebastian Kappert, Utz Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title | Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title_full | Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title_fullStr | Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title_full_unstemmed | Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title_short | Safety and Efficacy of the Transaxillary Access for Minimally Invasive Aortic Valve Surgery |
title_sort | safety and efficacy of the transaxillary access for minimally invasive aortic valve surgery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860976/ https://www.ncbi.nlm.nih.gov/pubmed/36676784 http://dx.doi.org/10.3390/medicina59010160 |
work_keys_str_mv | AT wilbringmanuel safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT alexioukonstantin safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT schmidttorsten safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT petrovasen safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT taghizadehwaghefiali safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT charitosefstratios safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT matschkeklaus safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT arztsebastian safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery AT kappertutz safetyandefficacyofthetransaxillaryaccessforminimallyinvasiveaorticvalvesurgery |